Your search returned 4 results.

Results
	1.	Down-regulation of topoisomerase II alpha is caused by up-regulation of GRP78. [electronic resource] by Gosky, David Chatterjee, Satadal Producer: 20030225 In: Biochemical and biophysical research communications vol. 300 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity. [electronic resource] by Hirota, Haruyo Gosky, David Berger, Nathan A Chatterjee, Satadal Producer: 20020405 In: International journal of oncology vol. 20 Availability: No items available. Save to lists Add to cart (remove)
	3.	A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia. [electronic resource] by Cooper, Brenda W Donaher, Erin Lazarus, Hillard M Green, Sylvan B Gosky, David M Rosenthal, Nancy S Berger, Sosamma J Li, Xiaolin Ingalls, Stephen T Hoppel, Charles L Gerson, Stanton L Producer: 20030303 In: Leukemia research vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia. [electronic resource] by Cooper, Brenda W Veal, Gareth J Radivoyevitch, Tomas Tilby, Michael J Meyerson, Howard J Lazarus, Hillard M Koc, Omer N Creger, Richard J Pearson, Graham Nowell, Geoff M Gosky, David Ingalls, Stephen T Hoppel, Charles L Gerson, Stanton L Producer: 20050329 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)